Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Yu Li

Showing results (71-80 of 282) with videos related to

Pageof 29
Sort By:
Bioorganic Chemistry|February 11, 2026
An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibitionXiuqi Wang, Rosa Anna DeFilippis, Huimin Geng, et al.
European Journal of Medical Genetics|September 6, 2023
Characteristics, differential diagnosis, individualized treatment, and prevention of hyperhomocysteinemia in newbornsYu-Yu Li, Jia Xu, Xue-Cheng Sun, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|April 17, 2025
[Advances in research on gender differences in autism spectrum disorders]Tong-Tong Jiang, Xiu-Qiong Li, Ting-Ting Zhao, et al.
World Journal of Gastroenterology|May 20, 2015
MET inhibitors for treatment of advanced hepatocellular carcinoma: A reviewXing-Shun Qi, Xiao-Zhong Guo, Guo-Hong Han, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 15, 2015
Pancreatic cancer: diagnosis and treatmentsHong-Yu Li, Zhong-Min Cui, Jiang Chen, et al.
Beilstein Journal of Organic Chemistry|November 12, 2025
Conformational effects on iodide binding: a comparative study of flexible and rigid carbazole macrocyclic analogsGuang-Wei Zhang, Yong Zhang, Le Shi, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Trends in Genetics : TIG|March 18, 2026
De novo mutations and environmental modifiers: lessons from neural tube defectsHong-Yu Li, Yuying Shen, Keng Ioi Vong, et al.
Oncology Reports|May 3, 2014
Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesisBin Liu, Zhen Wang, Hong-Yu Li, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Pageof 29

Showing results (71-80 of 282) with videos related to

Sort By:
Pageof 29
Bioorganic Chemistry|February 11, 2026
An unprecedented potent inhibitor of MV4-11 cells: investigations into the mechanism of action beyond FLT3 inhibitionXiuqi Wang, Rosa Anna DeFilippis, Huimin Geng, et al.
European Journal of Medical Genetics|September 6, 2023
Characteristics, differential diagnosis, individualized treatment, and prevention of hyperhomocysteinemia in newbornsYu-Yu Li, Jia Xu, Xue-Cheng Sun, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|April 17, 2025
[Advances in research on gender differences in autism spectrum disorders]Tong-Tong Jiang, Xiu-Qiong Li, Ting-Ting Zhao, et al.
World Journal of Gastroenterology|May 20, 2015
MET inhibitors for treatment of advanced hepatocellular carcinoma: A reviewXing-Shun Qi, Xiao-Zhong Guo, Guo-Hong Han, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 15, 2015
Pancreatic cancer: diagnosis and treatmentsHong-Yu Li, Zhong-Min Cui, Jiang Chen, et al.
Beilstein Journal of Organic Chemistry|November 12, 2025
Conformational effects on iodide binding: a comparative study of flexible and rigid carbazole macrocyclic analogsGuang-Wei Zhang, Yong Zhang, Le Shi, et al.
Bioorganic Chemistry|November 23, 2023
N-(3-Methoxyphenyl)-6-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-2-amine is an inhibitor of the FLT3-ITD and BCR-ABL pathways, and potently inhibits FLT3-ITD/D835Y and FLT3-ITD/F691L secondary mutantsXiuqi Wang, Rosa Anna DeFilippis, Yuet-Kin Leung, et al.
Trends in Genetics : TIG|March 18, 2026
De novo mutations and environmental modifiers: lessons from neural tube defectsHong-Yu Li, Yuying Shen, Keng Ioi Vong, et al.
Oncology Reports|May 3, 2014
Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesisBin Liu, Zhen Wang, Hong-Yu Li, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
Pageof 29